🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Xin Yao

Amicus Therapeutics (United Kingdom)

ORCID: 0000-0002-3594-4218

Also affiliated with Xiamen University

MedicineImmunology and MicrobiologyBusiness, Management and Accounting

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 4 papers. Top paper: “EZH2 regulates cancer cell migration through repressing TIMP-3 in non-small cell lung cancer”.

EZH2 regulates cancer cell migration through repressing TIMP-3 in non-small cell lung cancer

Medical Oncology(2013)10.1007/s12032-013-0713-6
N/A
0.596DataRank · unranked
52 citations

Zhibo Hou, Ping Zhan, Wei Zhao, Cunjie Chang, Jue Zou +6 more

Enterovirus spectrum from the active surveillance of hand foot and mouth disease patients under the clinical trial of inactivated Enterovirus A71 vaccine in Jiangsu, China, 2012-2013

Journal of Medical Virology(2015)10.1002/jmv.24275
N/A
0.477DataRank · unranked
23 citations

Lian-Lian Bian, Wei-Wei Lu, Jing-Xin Li, Qun-Ying Mao, Yi-Ping Wang +8 more

APOLLO: A randomized phase II double-blind study of olaparib versus placebo following curative intent therapy in patients with resected pancreatic cancer and a pathogenic BRCA1, BRCA2 or PALB2 mutation—ECOG-ACRIN EA2192.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps763
N/A
0.330DataRank · unranked
8 citations

Sung Chul Hong, Anup Kasi, Eileen M. O’Reilly, Shishir K. Maithel, Xin Yao +10 more

Apollo: A randomized phase II double-blind study of olaparib versus placebo following curative intent therapy in patients with resected pancreatic cancer and a pathogenic BRCA1, BRCA2, or PALB2 mutation—ECOG-ACRIN EA2192.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4202
N/A
0DataRank · unranked
3 citations

Sung Chul Hong, Anup Kasi, Eileen M. O’Reilly, Shishir K. Maithel, Xin Yao +10 more